Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

James K. Kirklin, Rongbing Xie, Jennifer Cowger, Theo M.M.H. de By, Takeshi Nakatani, Stephan Schueler, Rhiannon Taylor, Jenny Lannon, Paul Mohacsi, Jan Gummert, Daniel Goldstein, Kadir Caliskan, Margaret M. Hannan

Research output: Contribution to journalArticlepeer-review

112 Scopus citations


The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.

Original languageEnglish (US)
Pages (from-to)685-691
Number of pages7
JournalJournal of Heart and Lung Transplantation
Issue number6
StatePublished - Jun 2018


  • International Society for Heart and Lung Transplantation
  • adverse events
  • mechanical circulatory support
  • outcomes
  • risk factors
  • ventricular assist devices

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation


Dive into the research topics of 'Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry'. Together they form a unique fingerprint.

Cite this